| Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial C Salvarani, G Dolci, M Massari, DF Merlo, S Cavuto, L Savoldi, P Bruzzi, ... JAMA internal medicine 181 (1), 24-31, 2021 | 746 | 2021 |
| Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial F Perrone, MC Piccirillo, PA Ascierto, C Salvarani, R Parrella, AM Marata, ... Journal of translational medicine 18 (1), 405, 2020 | 147 | 2020 |
| RCT-TCZ-COVID-19 Study Group. Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial C Salvarani, G Dolci, M Massari, DF Merlo, S Cavuto, L Savoldi, P Bruzzi, ... JAMA Intern Med 181 (1), 24-31, 2021 | 92 | 2021 |
| Methodological quality of studies evaluating the burden of drug-resistant infections in humans due to the WHO Global Antimicrobial Resistance Surveillance System target bacteria MD Pezzani, B Tornimbene, C Pessoa-Silva, M De Kraker, S Rizzardo, ... Clinical Microbiology and Infection 27 (5), 687-696, 2021 | 26 | 2021 |
| Disseminated Mycobacterium chimaera infection after open heart surgery in an Italian woman: a case report and a review of the literature S Chiesi, D Piacentini, ND Salerno, D Luise, M Peracchi, E Concia, ... Infez Med 25 (3), 267-269, 2017 | 22 | 2017 |
| Efficacy of β‐lactam/β‐lactamase inhibitors to treat extended‐spectrum beta‐lactamase‐producing Enterobacterales bacteremia secondary to urinary tract infection … LC Pierrotti, E Pérez‐Nadales, M Fernández‐Ruiz, B Gutiérrez‐Gutiérrez, ... Transplant Infectious Disease 23 (3), e13520, 2021 | 13 | 2021 |
| How to ‘SAVE’antibiotics: effectiveness and sustainability of a new model of antibiotic stewardship intervention in the internal medicine area E Carrara, M Sibani, L Barbato, F Mazzaferri, ND Salerno, M Conti, ... International Journal of Antimicrobial Agents 60 (5-6), 106672, 2022 | 7 | 2022 |
| Risk factors for colonization with multidrug-resistant Gram-negative bacteria and Clostridioides difficile in Long Term Care Facilities (LTCFs) residents: the evidence from 27 … AM Azzini, G Be, L Naso, L Lambertenghi, ND Salerno, I Coledan, ... Frontiers in Cellular and Infection Microbiology 13, 1155320, 2023 | | 2023 |
| Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial P Francesco, MC Piccirillo, PA Ascierto, S Carlo, P Roberto, AM Marata, ... JOURNAL OF TRANSLATIONAL MEDICINE, 2021 | | 2021 |
| Efficacy of ß-lactam/ß-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing enterobacterales bacteremia secondary to urinary tract infection in kidney … N j Muller, O Manuel, H Arslan, I Hasanoglu, ML Oliva, S Chiese, ... Universidade Federal de Minas Gerais, 2021 | | 2021 |
| Tocilizumab for patients with COVID-19 pneumonia. The TOCIVID-19 phase 2 trial (preprint) F Perrone, MC Piccirillo, PA Ascierto, C Salvarani, R Parrella, AM Marata, ... | | 2020 |
